Johanna M. Hoppe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Johanna M. Hoppe has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Andreas Frick
Department of Medical Sciences, Experimental Cognitive and Affective Neuroscience Lab, Uppsala University, Uppsala, Sweden
1 shared publication Bengt Långström
Department of Chemistry, Uppsala University, Uppsala, Sweden
1 shared publicationClas Linnman
Department of Anesthesiology, Perioperative and Pain Medicine, Boston Children's Hospital, and Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
1 shared publicationEmily A. Holmes
Department of Psychology, Uppsala University, Uppsala, Sweden; Division of Psychology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
1 shared publicationFredrik Åhs
Department of Psychology, Uppsala University, Uppsala, Sweden
1 shared publication- Lars von Knorring
Department of Neuroscience, Psychiatry, Uppsala University, Uppsala, Sweden
1 shared publication
Latest Publications
- Open Access
- 24 February 2022
- Published by Elsevier in Consciousness and Cognition
- Vol. 99, 103286
Hotspots in the immediate aftermath of trauma – Mental imagery of worst moments highlighting time, space and motion
- 24 February 2022
- Published by Elsevier in Consciousness and Cognition
- Vol. 99, 103286
Open AccessHotspots in the immediate aftermath of trauma – Mental imagery of worst moments highlighting time, space and motion
- Open Access
- 28 August 2018
- Published by Springer Nature in Translational Psychiatry
- Vol. 8 (1) , 168
Association between amygdala neurokinin-1 receptor availability and anxiety-related personality traits
Animal studies indicate that substance P (SP) and its preferred neurokinin-1 (NK1) receptor modulate stress and anxiety-related behavior. Alterations in the SP-NK1 system have also been observed in human anxiety disorders, yet little is known about the relation between this system and individual differences in personality traits associated with anxiety propensity and approach-avoidance behavior, including trait anxiety, neuroticism, and extraversion. Exploring this relation could provide important insights into the neurobiological underpinnings of human anxiety and the etiology of anxiety disorders, as anxious traits are associated with increased susceptibility to develop psychopathological conditions. Here we examined the relationship between central NK1 receptor availability and self-rated measures of trait anxiety, neuroticism, and extraversion. The amygdala was chosen as the primary region of interest since this structure has been suggested to mediate the effect of the SP-NK1 system on anxiety. Anxious traits and NK1 receptor availability, determined with positron emission tomography and the radiotracer [11C]GR205171, were measured in 17 healthy individuals. Voxel-wise analyses showed a significant positive correlation between bilateral amygdala NK1 receptor availability and trait anxiety, and a trend in similar direction was observed for neuroticism. Conversely, extraversion was found to be negatively associated with amygdala NK1 receptor availability. Extraversion also correlated negatively with the NK1 measure in the cuneus/precuneus and fusiform gyrus according to exploratory whole-brain analyses. In conclusion, our findings indicate that amygdala NK1 receptor availability is associated with anxiety-related personality traits in healthy subjects, consistent with a modulatory role for the SP-NK1 system in human anxiety.
- 28 August 2018
- Published by Springer Nature in Translational Psychiatry
- Vol. 8 (1) , 168
Open AccessAssociation between amygdala neurokinin-1 receptor availability and anxiety-related personality traits
Animal studies indicate that substance P (SP) and its preferred neurokinin-1 (NK1) receptor modulate stress and anxiety-related behavior. Alterations in the SP-NK1 system have also been observed in human anxiety disorders, yet little is known about the relation between this system and individual differences in personality traits associated with anxiety propensity and approach-avoidance behavior, including trait anxiety, neuroticism, and extraversion. Exploring this relation could provide important insights into the neurobiological underpinnings of human anxiety and the etiology of anxiety disorders, as anxious traits are associated with increased susceptibility to develop psychopathological conditions. Here we examined the relationship between central NK1 receptor availability and self-rated measures of trait anxiety, neuroticism, and extraversion. The amygdala was chosen as the primary region of interest since this structure has been suggested to mediate the effect of the SP-NK1 system on anxiety. Anxious traits and NK1 receptor availability, determined with positron emission tomography and the radiotracer [11C]GR205171, were measured in 17 healthy individuals. Voxel-wise analyses showed a significant positive correlation between bilateral amygdala NK1 receptor availability and trait anxiety, and a trend in similar direction was observed for neuroticism. Conversely, extraversion was found to be negatively associated with amygdala NK1 receptor availability. Extraversion also correlated negatively with the NK1 measure in the cuneus/precuneus and fusiform gyrus according to exploratory whole-brain analyses. In conclusion, our findings indicate that amygdala NK1 receptor availability is associated with anxiety-related personality traits in healthy subjects, consistent with a modulatory role for the SP-NK1 system in human anxiety.